Bulls vs Bears
Click to unlock major analysts' bullish and bearish positions by joining Benzinga Edge.
Comments
Loading...
Overview Rating
Speculative
GRI Bio (NASDAQ:GRI) Stock Quotes, Forecast and News Summary
GRI Bio Stock (NASDAQ: GRI) stock price, news, charts, stock research, profile.
Compare
EPS worse than industry
Earnings Per Share
EPS is the portion of a company's profit allocated to each outstanding share of common stock. It is a key metric for investors to assess a company's profitability.
Earnings Per Share
EPS is the portion of a company's profit allocated to each outstanding share of common stock. It is a key metric for investors to assess a company's profitability.
EPS worse than industry
FAQ
How do I buy GRI Bio (GRI) stock?
You can purchase shares of GRI Bio (NASDAQ:GRI) through any online brokerage.
Who are GRI Bio (GRI) competitors?
Other companies in GRI Bio’s space includes: CERo Therapeutics Hldgs (NASDAQ:CERO), Vincerx Pharma (NASDAQ:VINC), Syros Pharmaceuticals (NASDAQ:SYRS), Galecto (NASDAQ:GLTO) and Alzamend Neuro (NASDAQ:ALZN).
What is the forecast, or price target, for GRI Bio (GRI) stock?
GRI Bio has a consensus price target of $11.50.
What is the current price for GRI Bio (GRI)?
The stock price for GRI Bio (NASDAQ: GRI) is $0.75 last updated December 23, 2024 at 9:20 AM EST.
Does GRI Bio (GRI) pay a dividend?
A quarterly cash dividend of 0.51 per share of Class A Common Stock. The quarterly cash dividend was payable on December 27, 2019 to stockholders of record on December 19, 2019.
When is GRI Bio (NASDAQ:GRI) reporting earnings?
GRI Bio’s Q3 earnings are confirmed for Thursday, November 14, 2024.
Is GRI Bio (GRI) going to split?
There is no upcoming split for GRI Bio.
What sector and industry does GRI Bio (GRI) operate in?
GRI Bio is in the Health Care sector and Biotechnology industry. They are listed on the NASDAQ.